These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 35490900)
1. Jawarish Shahi: A special dosage form of herbal formulations for functional gastrointestinal disorders in Unani medicine- A comprehensive review. Mobeen A; Moazzam SW J Ethnopharmacol; 2022 Jul; 293():115319. PubMed ID: 35490900 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Jawarish Shahi a herbal formulation in irritable bowel syndrome: An open-labeled single-arm clinical trial. Moazzam SW; Mobeen A; Siddiqui MA J Tradit Complement Med; 2022 Nov; 12(6):529-535. PubMed ID: 36325243 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Evaluation of Unani Medicine, Including Single Drugs and Polyherbal Formulations with Special Reference to Neurodegenerative Disorders. Imran S; Ahmad W; Saltanat S Altern Ther Health Med; 2024 Sep; 30(9):54-64. PubMed ID: 39212516 [TBL] [Abstract][Full Text] [Related]
4. Herbal medicine in the treatment of functional gastrointestinal disorders: A systematic review with meta-analysis. Tan N; Gwee KA; Tack J; Zhang M; Li Y; Chen M; Xiao Y J Gastroenterol Hepatol; 2020 Apr; 35(4):544-556. PubMed ID: 31674057 [TBL] [Abstract][Full Text] [Related]
5. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Burns G; Carroll G; Mathe A; Horvat J; Foster P; Walker MM; Talley NJ; Keely S Am J Gastroenterol; 2019 Mar; 114(3):429-436. PubMed ID: 30839392 [TBL] [Abstract][Full Text] [Related]
6. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy. Dobrek Ł; Thor PJ Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640 [TBL] [Abstract][Full Text] [Related]
8. Scientific appraisal of Unani concept of islah-e-advia (rectification/purification of drugs) and its importance. Rahman S; Jahan N; Makbul SAA; Ahmad M; Gani MA J Ethnopharmacol; 2020 Aug; 258():112880. PubMed ID: 32360562 [TBL] [Abstract][Full Text] [Related]
9. Aatrilal (Ammi majus L.), an important drug of Unani system of medicine: A review. Usmani QI; Jahan N; Aleem M; Hasan SA J Ethnopharmacol; 2021 Aug; 276():114144. PubMed ID: 33930491 [TBL] [Abstract][Full Text] [Related]
10. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors. von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683 [TBL] [Abstract][Full Text] [Related]
11. Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS). Karpe AV; Liu JW; Shah A; Koloski N; Holtmann G; Beale DJ Metabolomics; 2022 Jun; 18(6):38. PubMed ID: 35687195 [TBL] [Abstract][Full Text] [Related]
12. Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. Rahimi R; Abdollahi M World J Gastroenterol; 2012 Feb; 18(7):589-600. PubMed ID: 22363129 [TBL] [Abstract][Full Text] [Related]
13. The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome. Yao X; Yang Y; Zhang S; Shi Y; Zhang Q; Wang Y BMC Gastroenterol; 2020 Jul; 20(1):209. PubMed ID: 32631285 [TBL] [Abstract][Full Text] [Related]
14. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders. Thumann TA; Pferschy-Wenzig EM; Moissl-Eichinger C; Bauer R J Ethnopharmacol; 2019 Dec; 245():112153. PubMed ID: 31408679 [TBL] [Abstract][Full Text] [Related]
15. Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast®) in general practice. Michael R; Bettina V; Eckehard L Complement Ther Med; 2022 Dec; 71():102873. PubMed ID: 35998755 [TBL] [Abstract][Full Text] [Related]
16. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses. Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. Talley NJ; Holtmann G; Walker MM J Gastroenterol; 2015 Jun; 50(6):601-13. PubMed ID: 25917563 [TBL] [Abstract][Full Text] [Related]
18. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease. Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target. Allescher HD; Abdel-Aziz H Dig Dis; 2017; 35 Suppl 1():18-24. PubMed ID: 29421789 [TBL] [Abstract][Full Text] [Related]
20. The Perspective of Unani Medicine in Understanding Hyperthyroidism. Alam A; Sofi G; Quamri A Altern Ther Health Med; 2023 Oct; 29(7):262-267. PubMed ID: 36455141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]